文献速递新发突发、热带与寄生虫病

分子时代的欧洲裂头蚴病(Spirometra)

Sparganosis (Spirometra) in Europe in the Molecular Era.
PubMed 文献 · Clin Infect Dis · 2021-01-01

裂头蚴病是由裂头属绦虫引起的一种被忽视的食源性和水源性疾病,其全球分布未得到充分认识。该病主要被视为东亚的人兽共患病,但其物种原产于包括欧洲在内的所有有人居住的大陆。研究首次提供了欧洲两种裂头属物种同时存在的分子证据,并回顾了当前分布以提高对该寄生虫的认识。

要点

  • 欧洲17个国家野生动物中已报告裂头属绦虫,确认17例本土和8例输入性人类临床病例。
  • 首次分子证据显示欧洲同时存在两种裂头属物种:S. erinaceieuropaei局限于欧洲,S. mansoni主要分布于亚洲和大洋洲并延伸至欧洲。
  • 该寄生虫在东欧常见,可能随入侵或迁徙的哺乳动物宿主扩大分布,增加人类感染风险。

核心结论

  • 裂头蚴病并非仅局限于东亚,欧洲存在本土人类病例和两种裂头属物种的共存。

研究设计与样本

  • 综述与分子流行病学分析,基于文献 critical review 和分子证据。

主要发现

  • 从17个欧洲国家的众多野生动物中报告了裂头属绦虫。
  • critical review 确认了17例本土和8例输入性人类临床病例。
  • 首次分子证据表明欧洲同时存在两种裂头属物种:S. erinaceieuropaei局限于欧洲,S. mansoni主要分布于亚洲和大洋洲并到达欧洲。

临床怎么用

  • 临床医生应认识到欧洲存在本土裂头蚴病风险,对相关暴露史患者考虑该病。
  • 在东欧等流行区,注意野生动物宿主和入侵物种可能扩大寄生虫分布。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sparganosis is a relatively neglected foodborne and waterborne disease caused by species of the tapeworm genus Spirometra, the global distribution of which has not been sufficiently recognized. Known mainly as a zoonosis of East Asia, its species are native to all inhabited continents including Europe. Spirometra has been reported from numerous wildlife species from 17 European countries, and a critical review confirmed 17 autochthonous and 8 imported human clinical cases. We present the first molecular evidence of the coincident presence of 2 species in Europe and review the current distribution to raise awareness of the parasite in this region. Spirometra erinaceieuropaei is restricted to Europe and Spirometra mansoni represents a lineage distributed mainly across Asia and Oceania that reaches Europe. The parasite is common in Eastern Europe and its distribution has potential to expand along with its invasive or migrating mammal hosts, spreading the risks of human infection.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kuchta R, Kołodziej-Sobocińska M, Brabec J, et al. Sparganosis (Spirometra) in Europe in the Molecular Era. Clin Infect Dis. 2021. PMID: 32702118. doi:10.1093/cid/ciaa1036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。